| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |